Synopsis
The hyperglycemic effect of insulin deficiency produced by the administration of insulin antiserum is well known. (Moloney and Coval, 1955; Wright, 1961) . However, similar experiments with antisera against glucagon have shown conflicting results: while Grey et al., (1970) demonstrated an acute blood glucose lowering effect of glucagon antiserum administered in 48-hrfasted adrenalectomized rat, a recent study conducted by Hoist et al. (1978) with a similar experimental aim revealed that antiserum treatment had no effect on blood glucose in rats fasted for 3 and 10 hr, in chemically sympathectomized and adrenomedulectomized rats, or in 48-hrfasted, acutely adrenalectomized rats. The variable effect of glucagon antiserum administration thus observed might be partly due to a difference in crossreactivity of the antisera with glucagon-like immunoreactivity (GLI) since the antisera employed in these expriments were probably so-called nonspecific although this was not specifically mentioned.
We therefore studied the effect of the antisera specific for pancreatic glucagon on blood glucose and C-peptide immunoreactivity levels at the basal as well as in the hyperglucagonemic states caused by hypoglycemia or an intravenous infusion of arginine in rats. Experimental procedure Male Wistar rats weighing about 300 g were used for the experiments.
The 24-hr-fasted rats were anesthetized with hexobarbital and a small polyethylene catheter was threaded through an external jugular vein into the right atrium for blood sampling and injection of antiserum.
After a base line blood sample was obtained, 1 ml of the antigen-stripped antiserum (AGS) or normal rabbit serum (NRS) was injected and blood samples were obtained at an appropriate intervals depending upon the aim of the experiment.
Rat C-peptide was measured immunochemically and the details are given elsewhere (Yanaihara et al., 1978) . Free immunoreactive glucagon (IRG) was assayed according to the method of Hoist et al. (1978) or Nakagawa et al. (1973) using antiserum specific for pancreatic glucagon, OAL 123.
Results

Characterization of glucagon antiserum
Crossreactivity of one of the antisera to the C-terminal portion of glucagon, AGS 128, with gut glucagon-like immunoreactivity was 0.4% of that of antiserum GA 10 which crossreacted equally with pancreatic glucagon and gut GLI (Fig. 1) . 2. Neutralization of exogenous glucagon administered in vivo. (Fig. 2) Eight, 24-hr-fasted rats (4 control rats and 4 antiserum-treated rats) were rested for 10 min administration of an intracardial injection of 1 ml of serum or antiserum. Then glucagon in a dose of 200 ng/kg was injected. The glucagon injection caused a significant increase in blood glucose concentration after 5 and 15 min in control rats, whereas no significant change was found in the antiserum-treated rats except for a slight rise at 5 min. Plasma CPR concen- 10 min after an intravenous injection of 1 ml normal rabbit serum (NRS) or the antiserum (AGS) glucagon in a dose of 200 ng/kg was administered in 8, 24-hrfasted rats.
tration was significantly lower in the treated rats at 5 min. There was no free IRG was detected as early as 5 min after the glucagon injection, as well as at the end of the experiment in the AGS rats.
3. Effect of antiserum on blood glucose concentration a) Ten rats were fasted for 24 hr. Six rats then received 1 ml antiserum and 4 rats received control serum. As shown in Fig. 3 no significant changes in the blood glucose level were noted in either group except for a significant rise at 60 min. Free IRG was not detected during the experiment in the AGS rats. The Mean plasma CPR level tended to fall in the treated rats and the difference between the two groups was significant at 15 min. The antiserum C-peptide immunoreactivity (CPR) and free immunoreactive glucagon (IRG) levels in 24-hr-fasted rats. Six and four rats received 1 ml AGS and NRS intravenously, respectively.
had no significant effect on plasma concentration of p-hydroxybutyrate. b) Effects of the antiserum on plasma free IRG, CPR and blood glucose responses to an intravenous infusion of arginine at a rate of 0.5 g/kg for 15 min were studied in 19 fasted rats (10 treated and 9 control). Ten min after the antiserum injection, the infusion of arginine was started. As shown in the bottom panel of Fig. 4 , no significant change in blood glucose level was observed in the antiserum rats, but it tended to drop in the control group and the difference Fig. 4 . Effect of glucagon antiserum on blood glucose, CPR and free IRG levels in argine infused rats. Ten min after 1 ml of AGS injection in 10 rats or 1 ml of NRS in 9 rats, arginine solution was infused at a rate of 0.5 g/kg for 15 min. 
